Assessing Serum Neutralization Against SARS-CoV-2 with Pseudotyped Viruses

November 21st, 2023

Studying Host-Virus Interactions with Pseudotyped Viruses (Video) | JoVE

01:03 min

•

SARS-CoV-2 Pseudotype Virus Production and Serum Neutralization Assay (Video) | JoVE

04:50 min

•

Tobia Fantoni*¹, Michele Bissoli*¹, Chiara Stefani¹, Mauro Voi¹, Alexandrina Dabija¹, Rebecca Casula¹, Domenico Luca Minafra¹, Julys da Fonseca Palmeira², Enrique Roberto Argañaraz², Martin Mayora-Neto³, Nigel J. Temperton³, Donato Zipeto¹, Alessandra Ruggiero¹

¹Department of Neuroscience, Biomedicine and Movement, University of Verona, ²Laboratory of Molecular Neurovirology, Faculty of Health Science, University of Brasília, ³Viral Pseudotype Unit, Medway School of Pharmacy, Universities of Kent and Greenwich at Medway

* These authors contributed equally

Summary
Automatic Translation

English (Original)
العربية (Arabic)
中文 (Chinese)
dansk (Danish)
Nederlands (Dutch)
français (French)
Deutsch (German)
עברית (Hebrew)
हिंदी (Hindi)
italiano (Italian)
日本語 (Japanese)
한국어 (Korean)
norsk (Norwegian)
português (Portugese)
русский (Russian)
español (Spanish)
svenska (Swedish)
Türkçe (Turkish)

Pseudogetypeerde virussen (PV's) zijn replicatie-defecte virionen die worden gebruikt om gastheer-virusinteracties te bestuderen onder veiligere omstandigheden dan het hanteren van authentieke virussen. Hier wordt een gedetailleerd protocol gepresenteerd dat laat zien hoe SARS-CoV-2 PV's kunnen worden gebruikt om het neutraliserende vermogen van het serum van patiënten na COVID-19-vaccinatie te testen.

Article

Assessing Serum Neutralization Against SARS-CoV-2 with Pseudotyped Viruses

Get cutting-edge science videos from JoVE sent straight to your inbox every month.